When the next flu pandemic strikes or, perish the thought, the Ebola virus starts spreading in the United States, a newly expanded pharmaceutical plant in East Baltimore stands ready to respond.
Emergent BioSolutions, in partnership with the federal government, spent $80 million to double the size of its East Lombard Street plant near Johns Hopkins Bayview Medical Center.
{iframe}http://www.baltimoresun.com/business/bs-bz-emergent-expansion-20170505-story.html{/iframe}